Current and future therapies for hepatitis C virus infection
- PMID: 23944318
- PMCID: PMC3878654
- DOI: 10.1056/NEJMc1307589
Current and future therapies for hepatitis C virus infection
Conflict of interest statement
No potential conflict of interest relevant to this letter was reported.
Comment on
-
Current and future therapies for hepatitis C virus infection.N Engl J Med. 2013 May 16;368(20):1907-17. doi: 10.1056/NEJMra1213651. N Engl J Med. 2013. PMID: 23675659 Free PMC article. Review.
-
Current and future therapies for hepatitis C virus infection.N Engl J Med. 2013 Aug 15;369(7):679. doi: 10.1056/NEJMc1307589. N Engl J Med. 2013. PMID: 23944319 No abstract available.
References
-
- Highlights of prescribing information: Victrelis (boceprevir) capsules for oral use. Whitehouse Station, NJ: Merck; ( http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf).
-
- Summary of product characteristics: Victrelis. London: European Medicines Agency; ( http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Info...).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical